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ABSTRACT Ca2 influx through L-type channels is critical for numerous physiological functions. Relatively little is
known about modulation of neuronal L-type Ca2 channels. We studied modulation of neuronal CaV1.2c channels
heterologously expressed in HEK293 cells with each of the known muscarinic acetylcholine receptor subtypes.
Gq/11-coupled M1, M3, and M5 receptors each produced robust inhibition of CaV1.2c, whereas Gi/o-coupled M2 and
M4 receptors were ineffective. Channel inhibition through M1 receptors was studied in detail and was found to be
kinetically slow, voltage-independent, and pertussis toxin-insensitive. Slow inhibition of CaV1.2c was blocked by
coexpressing RGS2 or RGS3T or by intracellular dialysis with antibodies directed against Gq/11. In contrast, inhibition
was not reduced by coexpressing ARK1ct or Gt. These results indicate that slow inhibition required signaling by
Gq/11, but not G, subunits. Slow inhibition did not require Ca2 transients or Ca2 influx through CaV1.2c channels.
Additionally, slow inhibition was insensitive to pharmacological inhibitors of phospholipases, protein kinases, and
protein phosphatases. Intracellular BAPTA prevented slow inhibition via a mechanism other than Ca2 chelation. The
cardiac splice-variant of CaV1.2 (CaV1.2a) and a splice-variant of the neuronal/neuroendocrine CaV1.3 channel also
appeared to undergo slow muscarinic inhibition. Thus, slow muscarinic inhibition may be a general characteristic of
L-type channels having widespread physiological significance.
INTRODUCTION
Neuronal L-type Ca2 channels perform critical func-
tions in gene expression, neurosecretion, synaptic plas-
ticity, and circadian rhythms (Murphy et al., 1991; Bad-
ing et al., 1993; Jensen et al., 1999; Weisskopf et al.,
1999; Pennartz et al., 2002). In comparison with N-type
and P/Q-type Ca2 channels, little is known about the
mechanisms by which neuronal L-type channels are mod-
ulated (Dolphin, 1999). Because native cells may express
more than one L-type Ca2 channel isoform (Snutch et
al., 1991; Forti and Pietrobon, 1993; Hell et al., 1993)
and because these different isoforms cannot be easily
distinguished using pharmacological tools, the precise
molecular identity of endogenous L-type channels is of-
ten uncertain. Furthermore, distinct splice-variants of
Ca2 channels may be differentially modulated (Page et
al., 1998; Shistik et al., 1998; Bourinet et al., 1999;
Melliti et al., 2000). For these reasons, expression of
L-type channels in heterologous systems can provide
information difficult to obtain from native cells.
Five distinct subtypes (M1–M5) of muscarinic acetyl-
choline receptor are expressed in mammalian brain (Wei
et al., 1994). M1, M3, and M5 subtypes couple prefer-
entially to pertussis toxin (PTX)-insensitive Gq/11 pro-
teins, whereas M2 and M4 receptor subtypes couple
mainly to PTX-sensitive Gi/o proteins (Felder, 1995).
Muscarinic inhibition of native L-type channels has been
studied in mammalian central and peripheral neurons
(Mathie et al., 1992; Howe and Surmeier, 1995; Stewart
et al., 1999). In superior cervical ganglion (SCG) neurons
from mice and rats, native L-type channels are inhibited
through a slowly activating pathway linked to M1 mus-
carinic acetylcholine receptors (Bernheim et al., 1992;
Shapiro et al., 1999). However, less is known about
L-type channel modulation in other cell types (Dolphin,
1999), and the ability of muscarinic receptor subtypes
other than M1 to regulate L-type channels has been little
explored.
In the present study we reconstituted slow muscarinic
inhibition of cloned L-type Ca2 channels transiently ex-
pressed in human embryonic kidney (HEK293) cells. We
show that all three Gq/11-coupled muscarinic receptor
subtypes (M1, M3, and M5) generate robust inhibition of
the neuronal splice-variant CaV1.2c. Inhibition of CaV1.2c
was characterized in detail for M1 receptors and was found
to be kinetically slow, voltage-independent, and PTX-insen-
sitive. Slow muscarinic inhibition of CaV1.2c was blocked
by expression of RGS2 or RGS3T, two regulators of G
protein signaling known to interact with Gq/11. Pharma-
cological experiments suggest that the underlying signaling
pathway does not involve phospholipase A2, phospholipase
C, tyrosine kinases, serine/threonine kinases, or phospha-
tases. Significantly, we find that the cardiac splice-variant
of CaV1.2 (CaV1.2a) and a splice-variant of the neuronal/
neuroendocrine CaV1.3 channel also appear to undergo slow
muscarinic inhibition. Thus, slow muscarinic inhibition may
be a general feature of L-type channels that can influence
Ca2 influx in more cell types than previously thought.
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MATERIALS AND METHODS
Cell culture and transfection
Human embryonic kidney (HEK293) cells were obtained from the Amer-
ican Type Culture Collection (Manassas, VA) and propagated in culture
medium containing 90% DMEM (cat. no. 11995; Invitrogen/Gibco, Rock-
ville, MD), 10% defined fetal bovine serum (Hyclone Labs, Logan, UT),
and 50 g ml1 gentamicin. HEK293 cells of low passage number (20)
were trypsinized weekly and replated onto 60 mm culture dishes at 20%
confluence. CaPO4 precipitation was used to transfect these cells within
3–5 days of plating. The transfection mixture contained expression plas-
mids encoding a single type of Ca2 channel 1 subunit (CaV1.2c (Snutch
et al., 1991), CaV1.2a (Mikami et al., 1989), or CaV1.3 (Xu and Lipscombe,
2001)). In the case of CaV1.2c and CaV1.3, ancillary 2b (rat brain) and
3 (rabbit brain) Ca2 channel subunits were cotransfected at 1.25 g of
each cDNA per dish. In the case of CaV1.2a, ancillary 2a (rabbit skeletal
muscle) and 2a (rabbit heart) Ca2 channel subunits were cotransfected at
1.25 g of each cDNA per dish. An expression plasmid encoding the M1
muscarinic acetylcholine receptor was cotransfected at 0.5 g per dish. In
some experiments the M1 receptor was replaced by the M2 receptor (0.025
g per dish), the M3 receptor (0.125–0.625 g per dish), the M4 receptor
(0.125 g per dish), or the M5 receptor (0.5 g per dish). In selected
experiments, the transfection mixture included plasmids encoding Gly495-
Leu689 of -adrenergic receptor kinase 1 (ARK1ct), rod transducin (Gt),
untagged RGS2 or RGS2 fused in-frame to the carboxyl terminus of
enhanced green fluorescent protein (EGFP-RGS2), or EGFP-RGS3T at
1.25 g per dish. Transfections that did not include EGFP-RGS2 or
EGFP-RGS3T included a plasmid encoding EGFP at 0.125 g per dish.
The day after transfection, cells were briefly trypsinized and replated onto
12 mm round glass coverslips. After replating, cells were incubated at 37°C
for 6 h and then held at a lower temperature (29°C) overnight; this last step
appeared to promote channel expression. Electrophysiological experiments
were performed 24–32 h after replating. Successfully transfected cells
were visually identified by their green fluorescence under ultraviolet illu-
mination; only fluorescent cells were used for experiments.
Expression plasmids
cDNAs encoding rat brain CaV1.2c (GenBank accession number M67515)
and rat brain 2b (M86621) were in the expression vector pMT2 (Ge-
netics Institute, Cambridge, MA). Rabbit heart CaV1.2a (X15539) and
rabbit skeletal muscle 2a (M21948) were in pKCRH2 (Mishina et al.,
1984). Rat superior cervical ganglion neuron CaV1.3 (splice variant 11/
32/42a; AF370009) was in pcDNA6/V5-HisB (Invitrogen, Carlsbad,
CA). Rabbit brain 3 (X64300) was in pcDNA3 (Invitrogen). Rabbit heart
2a (X64297) was in pcDNA3.1 (Invitrogen). Human M1 muscarinic
acetylcholine receptor (X52068) was in pCD (Okayama and Berg, 1983).
Jellyfish enhanced green fluorescent protein (U55763) was in pEGFP
(Clontech, Cambridge, UK). Human M2 muscarinic acetylcholine receptor
(X15264) and bovine ARK1ct (M34019) were in pRK5 (Koch et al.,
1994). Human Gt (X63749), human M3 muscarinic acetylcholine recep-
tor (X15266), human M4 muscarinic acetylcholine receptor (X15265), and
human M5 muscarinic acetylcholine receptor (M80333) were in pcDNA
3.1. Human RGS2 (L13463) was in pcDNA3.1 or pEGFP-C2 (Clon-
tech). Human RGS3T (U27655) was in pEGFP-C3 (Clontech).
Electrophysiology
Large-bore patch pipettes were pulled from 100 l borosilicate glass
micropipettes and, unless noted otherwise, filled with the standard pipette
solution containing (in mM): 155 CsCl, 10 Cs2EGTA, 4 MgATP, 0.32
LiGTP, and 10 HEPES, adjusted to pH 7.4 with CsOH. In selected
experiments, a lower concentration of Cs2EGTA (0.1 mM) was used, or
Cs2EGTA was replaced by Cs4BAPTA (20 mM) and CsCl was reduced
accordingly. As a control for BAPTA, we used a pipette solution contain-
ing 5,5-dinitro-BAPTA (20 mM) and 145 CsCl, 10 Cs2EGTA, 4 MgATP,
0.32 LiGTP and 10 HEPES, pH 7.4 with CsOH. Aliquots of the pipette
solutions were stored at 80°C, kept on ice after thawing, and filtered at
0.22 m immediately before use, except where noted. Anti-Gq/11 or
preimmune rabbit IgG were added to the prefiltered standard pipette
solution at the indicated concentrations. In one series of experiments,
AMP-PNP (5 mM) was substituted for MgATP in the standard pipette
solution. On the same day as their use, U-73122 and U-73343 were
dissolved in DMSO to make a 10 mM stock solution which was subse-
quently diluted (1:1000) into prefiltered standard pipette solution. Quina-
crine was dissolved in double-distilled water to make a stock of 10 mM
(pH adjusted to 7.4 with CsOH) and then diluted (1:100) into prefiltered
standard pipette solution. Calcineurin auto-inhibitory peptide (CAIN) was
dissolved in prefiltered standard pipette solution. Pipette solutions were not
filtered following the addition of anti-Gq/11, control IgG, U-73122,
U-73343, quinacrine, or CAIN. The bath solution contained 145 NaCl, 40
CaCl2, 2 KCl, and 10 HEPES, adjusted to pH 7.4 with NaOH. Staurospor-
ine, genistein, and okadaic acid were dissolved in DMSO to make stock
solutions of 1 mM, 100 mM, and 100 M, respectively; these stocks were
stored in the dark at 20°C and diluted into the bath solution immediately
before use. The final concentration of DMSO in the bath was 0.01–0.1%,
which alone had no effects on Ca2 currents or their modulation. Carba-
chol (CCh) and atropine were dissolved directly in the bath solution.
Application of CCh was by bath exchange or local superfusion through a
macropipette positioned close to the cell. Coverslips were discarded fol-
lowing a single exposure to CCh.
Pipette tips were coated with paraffin to reduce capacitance. Filled
pipettes had DC resistances of 1.0–1.5 M. Ca2 currents were recorded
in the whole-cell, ruptured-patch mode. After forming a gigaohm seal in
the cell-attached configuration, residual pipette capacitance was compen-
sated using the negative capacitance circuit of the amplifier. The DC
resistance of the whole-cell configuration routinely exceeded 1 G. The
steady holding potential was90 mV. No corrections were made for liquid
junction potentials. Ca2 currents were evoked by 10 ms voltage-clamp
steps to30 mV (near the peak of the current-voltage relationship; see Fig.
1 b), delivered at 0.2 Hz unless otherwise noted. All Ca2 currents were
corrected online for linear cell capacitance and leakage currents using a
P/4 subtraction protocol. Leak-subtracted current amplitudes were mea-
sured at the time of peak inward current. Currents were filtered at 2–10 kHz
using the built-in Bessel filter (four-pole low-pass) of an Axopatch 200B
amplifier and sampled at 10–50 kHz using a Digidata 1200 analog-to-
digital board installed in a Gateway Pentium computer. The pCLAMP 8.0
software programs Clampex and Clampfit were used for data acquisition
and analysis, respectively. Figures were made using the software program
Origin (version 6.0).
Linear cell capacitance (C) was determined by integrating the area
under the whole-cell capacity transient, which was evoked by a 10 ms
voltage-clamp step from 90 to 80 mV. The average value of C was
30 	 1 pF (mean 	 SEM; n 
 237 cells). Voltage errors were minimized
by using low-resistance pipettes and electronic compensation. For each
cell, the time constant for decay of the whole-cell capacity transient () was
reduced as much as possible using the analog series resistance compensa-
tion circuit of the amplifier. Series resistance (RS) was calculated for each
cell as   (1/C). The average values of  and RS, measured before
electronic compensation, were 135	 7 s and 4.6	 0.2 M, respectively.
After electronic compensation, the average values of  and RS were 98 	
5 s and 3.6 	 0.1 M, respectively. Maximal Ca2 current amplitude
(test potential 30 mV) was 1020 	 73 pA. Maximal current density was
37 	 2 pA/pF. The average maximum voltage error after compensation
was 3.1 	 0.2 mV. Statistical comparisons were by ANOVA or unpaired
two-tailed t-test, with p  0.05 considered significant. Experiments were
conducted at room temperature (20–24°C).
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Reagents
Preimmune IgG and affinity-purified polyclonal antibody directed against
19 amino acids within the extreme carboxyl termini of Gq/11 (sc-392)
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). These
preparations were supplied in sterile saline without preservatives. Carba-
chol, atropine, staurosporine, genistein, AMP-PNP, and other standard
reagents were purchased from Sigma (St. Louis, MO). BAPTA and 5,5-
dinitro-BAPTA were purchased from Molecular Probes (Eugene, OR).
CAIN, okadaic acid, pertussis toxin, quinacrine, U-73122, and U-73343
were purchased from Calbiochem (La Jolla, CA). Expression plasmids
were generously provided by Drs. T. Snutch and G. Zamponi (CaV1.2c;
2b), T. Tanabe (CaV1.2a; 2a), D. Lipscombe (CaV1.3), V. Flockerzi
(2a), K. Campbell (3), D. Yue and E. Peralta (M2 receptor), S. Ikeda
(EGFP-RGS2) and R. Fisher (RGS3T; ARK1ct; M1 receptor), or were
obtained from the Guthrie Institute, Sayre, PA (Gt; RGS2; M3, M4 and
M5 receptors).
RESULTS
Reconstituted slow muscarinic inhibition of a
neuronal L-type Ca2 channel
Fig. 1 illustrates slow muscarinic inhibition of CaV1.2c
reconstituted in HEK293 cells. Application of a saturating
concentration of carbachol (CCh; 1 mM) triggered profound
inhibition of the expressed L-type Ca2 current (Fig. 1 a).
During steady-state inhibition, current amplitudes were re-
duced by 62 	 3% (mean 	 SEM; n 
 35). The smaller,
inhibited current activated with slightly slower kinetics
(Fig. 1 a, right), but this probably reflects a decrease in
Ca2-dependent channel inactivation due to the smaller
current amplitude, rather than voltage-dependent, G protein-
FIGURE 1 Reconstituted slow muscarinic inhibition of neuronal L-type Ca2 channels. Data from cells coexpressing M1 receptors (except in panel e)
and CaV1.2c, 2b, and 3 Ca2 channel subunits. The standard pipette solution containing 10 mM EGTA was used. Throughout the figures, application
of CCh (1 mM) is indicated by a heavy horizontal line. (a, left panel) Time-plot of inhibition through M1 receptors. Ca2 currents were evoked at 0.2 Hz
by 10-ms depolarizations from 90 to 30 mV. Maximum current amplitudes are plotted versus time. Linear cell capacitance (C) 
 17 pF; compensated
series resistance (RS) 
 6.1 M; the maximal voltage error (VE) in this recording was 4.5 mV. (a, right panel) Ca2 currents recorded at times indicated
in the plot at left. (b) Control I-V data (F) were obtained (at 0.2 Hz) before CCh application. CCh was then applied, and the onset of slow inhibition was
monitored by depolarizations to 30 mV delivered at 0.2 Hz. During steady-state slow inhibition, I-V data (E) were again obtained at 0.2 Hz. Symbols
represent data obtained from the same seven cells before and during CCh application. For each cell, current amplitudes were normalized to the peak current
recorded before applying CCh. The dashed line is the scaled, inhibited I-V relationship. (c) Whole-cell Ca2 conductances were calculated (assuming a
reversal potential of 90 mV) from I-V data obtained from each cell (e.g., panel b) before and during CCh application. The derived conductance data were
fit by a Boltzmann function (Origin, version 6.0). The dashed vertical line indicates V1/2, the midpoint of activation. (d) A standard three-pulse voltage
protocol was used to elicit currents before CCh application (1) and during (2) maximal slow inhibition of the Ca2 current. C 
 19 pF; RS 
 2.4 M;
VE 
 3.0 mV. (e) Inhibition of CaV1.2c currents through each of the five muscarinic acetylcholine receptor subtypes. Receptors were activated by 1 mM
CCh. Inhibition was measured as [1  (inhibited current/control current)]  100%. Error bars represent 	SEM.
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mediated channel inhibition (see below). As seen in Fig. 1
a, left, both the onset and the recovery from CCh-mediated
inhibition were slow. In a subset of experiments in which
CCh was rapidly applied (solution exchange complete
within 2 s), the half-time for onset of inhibition was 13 	
2 s (n 
 6). Inhibition was prevented (2 	 2%, n 
 5) by
simultaneous application of 1 mM atropine and CCh. Fur-
thermore, CCh failed to elicit modulation of CaV1.2c cur-
rents (0 	 0%, n 
 4) in cells not transfected with receptor
cDNA. These results show that channel inhibition was me-
diated through the cotransfected M1 muscarinic acetylcho-
line receptors.
In rodent SCG neurons, muscarinic receptors mediate
voltage-independent inhibition of endogenous L-type Ca2
channels (Mathie et al., 1992). To determine whether re-
constituted slow inhibition of CaV1.2c was similarly volt-
age-independent, we measured current-voltage (I-V) rela-
tionships before and during CCh application. As shown in
Fig. 1 b, the averaged I-V relationship was unchanged
during slow inhibition. To further test for a change in
voltage-dependence, I-V data were converted to conduc-
tance-voltage data and fit by a Boltzmann function to obtain
estimates of V1/2, the midpoint of activation. As illustrated
for a representative cell (Fig. 1 c), conductance-voltage
relationships were basically unaffected during slow inhibi-
tion. Thus, V1/2 was 19.6 	 1.3 mV before applying CCh
and 23.3 	 2.0 mV during the height of slow inhibition
(p 
 0.096, paired t-test; n 
 8). We also looked for
“kinetic slowing” and “prepulse facilitation,” two defining
features of the voltage-dependent form of Ca2 channel
inhibition (Elmslie et al., 1990). As depicted in Fig. 1 d,
currents did not exhibit noticeable kinetic slowing during
application of CCh. Furthermore, in seven of seven cells
currents were decreased in amplitude, rather than facilitated,
following a prepulse to 100 mV. Prepulses produced
similar effects before and during slow inhibition (Fig. 1 d).
Altogether, the above data suggest that reconstituted slow
muscarinic inhibition of CaV1.2c is voltage-independent.
In rodent SCG neurons, slow muscarinic inhibition of
native L-type Ca2 channels is mediated solely by M1
receptors (Bernheim et al., 1992; Shapiro et al., 1999). Can
the slow inhibitory pathway also be activated by other
muscarinic receptor subtypes? To address this question, we
coexpressed CaV1.2c with M2, M3, M4, or M5 receptors.
As summarized in Fig. 1 e, M3 and M5 receptors also
triggered profound inhibition of CaV1.2c. On average, cur-
rents were inhibited by 61 	 4% (n 
 12) through M3
receptors and by 67 	 8% (n 
 5) through M5 receptors.
Additionally, inhibition of CaV1.2c through M3 and M5
receptors was kinetically slow. In experiments where CCh
was rapidly applied, slow inhibition developed with a half-
time of 13	 1 s (n
 3) for M3 receptors and 11	 1 s (n

3) for M5 receptors, not different from inhibition through
M1 receptors (p 
 0.7, ANOVA). These experiments sug-
gest that each of the three Gq/11-coupled muscarinic re-
ceptor subtypes (M1, M3, and M5) is capable of activating
the slow inhibitory pathway. In contrast, no significant
modulation of CaV1.2c was produced through activation of
coexpressed M2 or M4 receptors (Fig. 1 e). To confirm
functional expression of the latter two receptor subtypes, we
coexpressed them with non-L-type Ca2 channels. M2 and
M4 receptors each generated strong modulation of CaV2.2
and CaV2.3 channels (Melliti et al., 1999; Meza et al., 1999;
and data not shown).
Like other L-type channels, CaV1.2c exhibits Ca2-de-
pendent inactivation (Charnet et al., 1994) which can be
triggered either by influx of extracellular Ca2 or by Ca2
released from intracellular stores. We used two separate
approaches to determine whether Ca2-dependent inactiva-
tion contributed to slow muscarinic inhibition in our exper-
iments. In the first approach, we switched to a pipette
solution containing reduced (0.1 mM) EGTA, under the
assumption that reduced Ca2 buffering should produce
enhanced Ca2-dependent inactivation. As shown in Fig. 2
a, CCh evoked an additional fast and transient component of
inhibition under these conditions. The amplitude of this fast
FIGURE 2 Slow muscarinic inhibition does not require Ca2 release from internal stores or influx of extracellular Ca2. Data from cells coexpressing
CaV1.2c and M1 receptors. (a, left panel) Experiment with low (0.1 mM) EGTA in the pipette solution. C 
 46 pF; RS 
 0.7 M; VE 
 2.3 mV. (a, right
panel) Ca2 currents recorded at times indicated at left. (b) During the initial 60 s of CCh application (dashed vertical lines), Ca2 currents were not evoked
and the membrane potential was clamped at 90 mV. C 
 23 pF; RS 
 3.8 M; VE 
 11.6 mV.
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component was quite variable from cell to cell, ranging
from 32 to 77% (55 	 6%, n 
 9). The time course of the
fast component closely resembled that of Ca2 transients
recorded from tsA201 cells expressing M1 receptors (Sha-
piro et al., 2000). One explanation for this fast component is
Ca2-dependent inactivation of CaV1.2c in response to in-
tracellular Ca2 release. However, it is important to note
that slow muscarinic inhibition of CaV1.2c was unchanged
in recordings made with low EGTA (Fig. 2 a). For example,
the kinetically distinct slow phase accounted for 57 	 5%
(n 
 9) inhibition of CaV1.2c in these experiments, indis-
tinguishable from results obtained with the standard (10
mM EGTA) pipette solution (Fig. 1, a and e). These results
suggest that release of intracellular Ca2 is not required for
slow muscarinic inhibition of CaV1.2c. In the second ap-
proach, cells were continuously clamped at 90 mV during
the initial 60 s of CCh application. As illustrated in Fig. 2 b,
robust channel inhibition developed during this interval, in
the absence of evoked inward Ca2 currents. Altogether,
CaV1.2c currents were inhibited by 69	 12% (n
 3) while
cells were continuously clamped at 90 mV, not different
from the inhibition that develops while Ca2 currents are
evoked every 5 s (Fig. 1 a and e). Thus, slow muscarinic
inhibition does not require Ca2 influx through CaV1.2c
channels. Taken together, these experiments indicate that
Ca2-dependent inactivation does not contribute to slow
muscarinic inhibition of CaV1.2c (see also Discussion).
Slow muscarinic inhibition is mediated by Gq/11
M1 receptors preferentially couple to pertussis toxin (PTX)-
insensitive G proteins of the Gq/11 subfamily (Felder,
1995). To confirm exclusive coupling of M1 receptors to
PTX-insensitive G proteins in our experiments, we incu-
bated cells with PTX (1 g ml1) for 4–6 h before exper-
iments. As shown in Fig. 3, a and f, pretreatment with PTX
had no effect on inhibition of CaV1.2c through M1 recep-
tors. Altogether, CCh inhibited the current by 63 	 8% in
eight PTX-treated cells, compared with 62 	 3% inhibition
in 35 untreated control cells. Thus, slow inhibition of
CaV1.2c was mediated by PTX-insensitive G proteins.
To examine whether Gq/11 or another PTX-insensitive
G protein is responsible for slow muscarinic inhibition of
FIGURE 3 Slow muscarinic inhibition is mediated by Gq/11 and is blocked by RGS proteins. Data from cells coexpressing CaV1.2c and M1 receptors.
(a) Cells were incubated with PTX (1 g ml1) for at least 4 h before recording. C
 18 pF; RS 
 3.7 M; VE
 1.1 mV. (b) Slow inhibition is attenuated
by antibodies directed against Gq/11. Before CCh was applied, cells were dialyzed for 2–10 min with a pipette solution containing a 1:100 dilution (2
ng l1) of a polyclonal antibody directed against a peptide (19 amino acids in length) found within the extreme carboxyl-terminus of Gq/11. C 
 14
pF; RS 
 8.5 M; VE 
 8.2 mV. (c) Data from a cell coexpressing ARK1ct. C 
 25 pF; RS 
 2.1 M; VE 
 4.6 mV. (d) Data from a cell coexpressing
EGFP-RGS2. C 
 18 pF; RS 
 3.3 M; VE 
 2.4 mV. (e) Data from a cell coexpressing EGFP-RGS3T. C 
 85 pF; RS 
 1.1 M; VE 
 0.5 mV. (f)
Summary. Data labeled “RGS2” are from cells transfected with untagged RGS2 (i.e., not fused to EGFP). Data labeled “IgG control” are from cells dialyzed
through the pipette for 8 min or longer with a 1:100 dilution (2 ng l1) of preimmune rabbit IgG. Dashed vertical line indicates average inhibition in
control cells (cf. Fig. 1). Error bars represent 	SEM.
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CaV1.2c, we dialyzed cells with a polyclonal antibody di-
rected against the extreme carboxyl-termini of Gq and
G11. This antibody uncouples signaling through Gq/11-
coupled thromboxane A2 receptors (Shenker et al., 1991)
and attenuates Gq/11-mediated muscarinic inhibition of
endogenous M-type K channels in rat SCG neurons (Caul-
field et al., 1994). As shown in Fig. 3 b, anti-Gq/11
significantly reduced inhibition of CaV1.2c through M1
receptors. Thus, CCh elicited only 21 	 6% (n 
 9)
inhibition in cells dialyzed with anti-Gq/11, compared
with 70 	 8% (n 
 5) inhibition in cells dialyzed with
preimmune rabbit IgG (Fig. 3 f). Anti-Gq/11 appeared to
have a stronger blocking effect in cells dialyzed for longer
periods of time; however, due to variations in pipette-cell
access resistance it was difficult to establish a tight corre-
lation between length of dialysis and effectiveness of the
antibody. The residual CCh-mediated inhibition noted in
some cells (e.g., Fig. 3 b) is probably attributable to incom-
plete dialysis with anti-Gq/11 rather than to the involve-
ment of another G protein. Altogether, these results strongly
imply that heterotrimeric Gq/11 proteins mediate slow
muscarinic inhibition of CaV1.2c.
Under similar experimental conditions, M1 receptors in
rat SCG neurons inhibit endogenous N-type Ca2 channels
through a voltage-independent pathway that involves sig-
naling by both Gq/11 and G subunits (Kammermeier et
al., 2000). To determine whether the voltage-independent
inhibition of CaV1.2c studied here (Fig. 1, b–d) also re-
quires signaling by both Gq/11 and G, we expressed the
carboxyl-terminal region of -adrenergic receptor kinase 1
(ARK1ct), which sequesters free G subunits (Koch et
al., 1994), including those released through activation of
M1 receptors (Melliti et al., 2000). As shown in Fig. 3 c,
neither the kinetics nor the magnitude of slow inhibition
were significantly altered by coexpressing ARK1ct. Inhi-
bition was similarly unaffected by coexpressing Gt (Fig. 3
f), which also strongly buffers free G subunits (Federman
et al., 1992; Kammermeier and Ikeda, 1999). These results
indicate that slow muscarinic inhibition of CaV1.2c does not
require signaling by G.
Slow muscarinic inhibition is blocked by RGS2
and RGS3T
Regulators of G-protein signaling (RGS proteins) function
as GTPase-accelerating proteins (GAPs) and/or as effector
antagonists for certain classes of G subunits (Berman and
Gilman, 1998). Previous studies have demonstrated that
RGS proteins can influence the G protein-dependent mod-
ulation of N-type, P/Q-type, and R-type Ca2 channels
(Jeong and Ikeda, 1998; Diverse´-Pierluissi et al., 1999;
Melliti et al., 1999, 2000, 2001; Kammermeier et al., 2000;
Mark et al., 2000). However, no previous work has shown
that RGS proteins influence L-type channel modulation.
Both RGS2 and RGS3T are known to antagonize signaling
by Gq/11 (Heximer et al., 1997; Chatterjee et al., 1997;
Scheschonka et al., 2000). As illustrated in Fig. 3, d–f, slow
muscarinic inhibition of CaV1.2c was effectively blocked by
coexpressing either EGFP-RGS2 or EGFP-RGS3T. Identi-
cal results were obtained with untagged RGS2 (Fig. 3 f). In
separate experiments (not shown), we found that RGS2 also
blocked slow muscarinic inhibition of CaV1.2c through M3
or M5 receptors. Together with our antibody experiments
(Fig. 3, b and f), these results support the conclusion that
Gq/11 activates the slow muscarinic pathway in HEK293
cells (see also Delmas et al., 1998; Haley et al., 2000).
Additionally, these findings suggest that certain RGS pro-
teins may antagonize slow muscarinic inhibition of L-type
channels in native cells.
Slow muscarinic inhibition does not appear to
involve phospholipase C or phospholipase A2
Phospholipase C-1 (PLC-1) is the principal downstream
effector enzyme of Gq/11 (Smrcka et al., 1991). In the
canonical signaling pathway, PLC-1 cleaves phosphatidyl-
inositol-4,5-bisphosphate (PIP2) into inositol trisphosphate
(IP3) and 1,2-diacylglycerol (DAG). IP3 triggers Ca2 re-
lease from intracellular stores (Berridge, 1993), whereas
DAG activates both conventional and novel isozymes of
protein kinase C (Mellor and Parker, 1998). We used the
aminosteroid U-73122 to test for involvement of PLC in
slow muscarinic inhibition of CaV1.2c. In support of a
previous report by Macrez-Lepretre et al. (1996), we ob-
served that U-73122 strongly blocked CaV1.2c currents
when applied extracellularly. To circumvent this problem,
U-73122 was applied in the pipette solution. Altogether, in
cells dialyzed with 10 M U-73122 for at least 8 min, CCh
still inhibited the Ca2 current by 46 	 6% (n 
 10).
Because CCh produced similar inhibition (39 	 11%; n 

3) in cells dialyzed for equivalent times with 10 M
U-73343, the inactive analog of U-73122, we conclude that
the weak effects of these compounds are nonspecific. We
also used quinacrine to assess the potential involvement of
phospholipase A2 (PLA2). In five cells dialyzed with 100
M quinacrine for at least 6 min, CCh still inhibited the
Ca2 current by 50 	 5%. From these results, we conclude
that slow muscarinic inhibition of CaV1.2c is unlikely to
involve PLC or PLA2.
Slow muscarinic inhibition does not appear
to involve protein phosphorylation
or dephosphorylation
We used several pharmacological tools to further character-
ize the pathway responsible for slow muscarinic inhibition
of CaV1.2c. As illustrated in Fig. 4 a, slow inhibition was
undiminished by 100 nM staurosporine, which inhibits pro-
tein kinase A, protein kinase C, protein kinase G, Ca2/
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calmodulin-activated protein kinases, and some members of
the Src family of tyrosine kinases (Hanke et al., 1996). On
average, CCh inhibited Ca2 currents by 67 	 6% (n 
 7)
in staurosporine-treated cells, not different from controls.
Slow inhibition was also undiminished by 100 M
genistein, a broad-spectrum inhibitor of protein tyrosine
kinases. As previously reported for other Ca2 channels
(Meza et al., 1999), genistein alone strongly reduced Ca2
currents (Fig. 4 b). This effect may be due to inhibition of
basally active tyrosine kinases or (more likely) direct chan-
nel block. Once current amplitudes had stabilized in the
continued presence of genistein, CCh produced 72 	 4%
(n 
 6) inhibition, similar to controls. These data suggest
that slow muscarinic inhibition does not involve serine/
threonine kinases or tyrosine kinases.
As shown in Fig. 4 c, robust slow muscarinic inhibition of
CaV1.2c persisted in cells dialyzed with a pipette solution
containing nonhydrolyzable AMP-PNP (5 mM) in place of
ATP. On average, inhibition was 52 	 7% (n 
 10) in
AMP-PNP-dialyzed cells. This result suggests that phos-
phorylation is not required for slow inhibition. The onset of
inhibition appeared somewhat slower in AMP-PNP-dia-
lyzed cells (Fig. 4 c) than in control cells, but this possible
effect was not pursued. However, inhibition was clearly
irreversible in cells dialyzed with AMP-PNP (Fig. 4 c). For
example, whereas Ca2 currents recovered by 66 	 10%
(n
 14) following CCh washout in control cells, currents in
AMP-PNP-dialyzed cells recovered by only 6 	 4% (n 

10). This significant difference (p  0.0001) suggested that
phosphorylation might be required for recovery from slow
inhibition—in this case, the onset of slow inhibition would
reflect dephosphorylation. To assess this possibility we used
okadaic acid, which inhibits protein phosphatases PP1,
PP2A, PP4, PP5, and PP6 at relatively low concentrations
(Herzig and Neumann, 2000). Cells were exposed to 50 nM
okadaic acid in the culture medium for 2 h before experi-
ments, and the same concentration of okadaic acid was
continuously present in the bath solution. We also per-
formed experiments in which 10 M CAIN, a specific
inhibitor of PP2B (calcineurin), was added to the pipette
FIGURE 4 Slow muscarinic inhibition does not appear to involve protein kinases or phosphatases. Data from cells coexpressing CaV1.2c and M1
receptors. (a) Cells were exposed to 100 nM staurosporine (Stauro) dissolved in the bath solution. Staurosporine application is indicated by a hatched
horizontal bar. C 
 25 pF; RS 
 5.7 M; VE 
 8.7 mV. (b) Cells were exposed to 100 M genistein dissolved in the bath solution. Genistein application
is indicated by a hatched horizontal bar. C 
 47 pF; RS 
 2.2 M; VE 
 1.8 mV. (c) Cells were dialyzed with the standard pipette solution, modified
to contain 5 mM AMP-PNP in place of MgATP, for at least 5 min before applying CCh. C 
 22 pF; RS 
 3.4 M; VE 
 1.7 mV. (d) Cells were exposed
to 50 nM okadaic acid for at least 2 h before and during experiments. C 
 27 pF; RS 
 8.6 M; VE 
 4.9 mV. (e) Cells were dialyzed with the standard
pipette solution containing 10 M calcineurin autoinhibitory peptide (CAIN) for at least 6 min before applying CCh. C 
 18 pF; RS 
 10.8 M; VE 

5.2 mV. (f) Summary. Dashed vertical line indicates average inhibition in control cells. Error bars represent 	SEM.
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solution. CAIN has been previously used to block dopami-
nergic inhibition of native L-type Ca2 channels in striatal
neurons (Herna´ndez-Lo´pez et al., 2000). As shown in Fig. 4,
d and e, neither phosphatase inhibitor decreased slow mus-
carinic inhibition of CaV1.2c. On average, CCh produced
69 	 6% (n 
 7) inhibition in cells exposed to okadaic acid
and 57	 5% (n
 6) inhibition in cells dialyzed with CAIN
(Fig. 4 f). We cannot account for the apparent irreversibility
of slow inhibition in cells dialyzed with AMP-PNP. How-
ever, taken together, our results suggest that slow musca-
rinic inhibition does not involve protein phosphorylation or
dephosphorylation.
BAPTA blocks slow muscarinic inhibition
independently of Ca2 chelation
Previous studies have found that high intracellular concen-
trations of BAPTA disrupt slow muscarinic inhibition of
native L-type Ca2 currents in rat SCG neurons (Mathie et
al., 1992) and striatal neurons (Howe and Surmeier, 1995).
In the present experiments, we found that a pipette solution
containing 20 mM BAPTA completely blocked inhibition
of CaV1.2c through M1 receptors (Fig. 5 a). Thus, CCh
inhibited CaV1.2c currents by only 2 	 2% (n 
 12) in
BAPTA-dialyzed cells. However, because BAPTA may
have actions unrelated to Ca2 chelation (Beech et al.,
1991; Meza et al., 1999), we also performed experiments in
which cells were dialyzed with a pipette solution containing
5,5-dinitro-BAPTA (20 mM). This latter molecule has a
much lower affinity for Ca2 (Kd 
 7 mM) than regular
BAPTA (Kd 
 165 nM). The pipette solution containing
5,5-dinitro-BAPTA also included 10 mM EGTA to buffer
intracellular Ca2 at the same concentration as in control
cells. Significantly, 5,5-dinitro-BAPTA blocked musca-
rinic inhibition of CaV1.2c as effectively as BAPTA (Fig. 5
b). On average, CCh produced only 1 	 1% inhibition in
cells dialyzed with 5,5-dinitro-BAPTA (n 
 6). These
results show that BAPTA blocks slow muscarinic inhibition
of L-type Ca2 channels reconstituted in HEK293 cells, as
it does in rat SCG neurons (Mathie et al., 1992) and striatal
neurons (Howe and Surmeier, 1995). However, the effect of
5,5-dinitro-BAPTA indicates that Ca2 chelation is not
the mechanism by which BAPTA blocks slow muscarinic
inhibition.
Other L-type Ca2 channels also undergo slow
muscarinic inhibition
To determine whether slow muscarinic inhibition is an
exclusive property of CaV1.2c or a more general character-
istic of L-type channels, we cotransfected cells with M1
receptors and CaV1.2a, the cardiac splice-variant of CaV1.2.
CaV1.2a was coexpressed with ancillary 2a (cardiac) and
2a (skeletal muscle) subunits. As shown in Fig. 6 a,
CaV1.2a was substantially inhibited (66 	 7%; n 
 8)
through M1 receptors. The speed of onset and recovery
from inhibition closely resembled that of the neuronal
splice-variant CaV1.2c (see Fig. 1 a). These results suggest
that neuronal and cardiac splice-variants of CaV1.2 can both
be inhibited through a slow muscarinic pathway. Further-
more, the identity of the ancillary subunits does not appear
to be critical; slow inhibition occurred when either 2a/
2a or 3/2b subunits were expressed.
FIGURE 5 Slow muscarinic inhibition is blocked by BAPTA and 5,5-dinitro-BAPTA. Data from cells coexpressing CaV1.2c and M1 receptors. (a) Cells
were dialyzed with a pipette solution containing 20 mM BAPTA for at least 5 min before recording Ca2 currents. The inset shows Ca2 currents recorded
before and during exposure to 1 mM CCh. C 
 14 pF; RS 
 4.2 M; VE 
 4.6 mV. (b) Cells were dialyzed with a pipette solution containing
55-dinitro-BAPTA (20 mM) plus EGTA (10 mM) for at least 5 min before recording Ca2 currents. The inset shows Ca2 currents recorded before and
during exposure to 1 mM CCh. C
 19 pF; RS 
 3.8 M; VE
 0.8 mV. (c) Summary. Control data (10 EGTA) from Fig. 1 e are included for comparison.
Error bars represent 	SEM.
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We next examined modulation of CaV1.3, which repre-
sents a distinct family of neuronal/neuroendocrine L-type
channels. For these experiments we used a splice-variant
(11/32/42a) of CaV1.3 cloned from rat SCG neurons (Xu
and Lipscombe, 2001). As illustrated in Fig. 6 b, CaV1.3
was robustly inhibited through M1 receptors. On average,
CCh produced 48 	 5% inhibition of CaV1.3 currents (n 

16). Both the onset and recovery from inhibition were slow,
very similar to CaV1.2a and CaV1.2c. These results suggest
that both CaV1.2 and CaV1.3 Ca2 channel families are
inhibited through a slow muscarinic pathway. Therefore,
slow muscarinic inhibition appears to be a general charac-
teristic of L-type Ca2 channels.
DISCUSSION
We have reconstituted slow muscarinic inhibition of L-type
Ca2 channels in HEK293 cells. Reconstituted inhibition of
CaV1.2c closely resembles slow muscarinic inhibition of
endogenous L-type Ca2 channels in central and peripheral
neurons (Mathie et al., 1992; Howe and Surmeier, 1995;
Stewart et al., 1999). Our present findings complement and
extend previous studies indicating that slow muscarinic
inhibition of cloned M-type K channels (Shapiro et al.,
2000) and cloned N-type Ca2 channels (Melliti et al.,
2001) can be faithfully reproduced in non-neuronal cells.
The overall similarity between slow muscarinic inhibition in
HEK293 cells and neurons strongly suggests that the un-
derlying signaling pathway is present in both cell types. The
ability to reconstitute slow muscarinic inhibition in heter-
ologous systems should be helpful in further elucidating the
molecular components of this signaling pathway.
M1 receptors are solely responsible for mediating slow
muscarinic inhibition of L-type and N-type Ca2 channels
and M-type K channels in rodent SCG neurons (Hamilton
et al., 1997; Shapiro et al., 1999). However, M1 receptors
are not required for muscarinic suppression of M-type K
currents in pyramidal neurons (Rouse et al., 2000) or in
CA1 or CA3 neurons of mouse hippocampus (Fisahn et al.,
2002). We found that all three Gq/11-coupled muscarinic
receptors (M1, M3, and M5) could trigger slow inhibition of
CaV1.2c (Fig. 1 e). These findings support the idea that M3
and M5 receptors activate the slow muscarinic inhibitory
pathway in some cell types in vivo.
Gi/o-coupled M2 and M4 receptors failed to modulate
CaV1.2c channels in our experiments (Fig. 1 e). In a previ-
ous study, Pemberton and Jones (1997) reported that M2
and M4 receptors inhibited endogenous L-type Ca2 chan-
nel currents in a mouse embryonic fibroblast cell line (NIH
3T3). In their experiments, channel inhibition through M2
and M4 receptors was PTX-sensitive and thus clearly dif-
ferent from slow muscarinic inhibition of CaV1.2c in our
experiments (Fig. 3 a). Pemberton and Jones (1997) also
concluded that channel inhibition through M1 receptors was
mediated by protein kinase C. In contrast, our present re-
sults (Fig. 4) indicate that protein kinases are not involved
in slow muscarinic inhibition of CaV1.2c. One difficulty in
comparing our results with those of Pemberton and Jones
(1997) is that the molecular identity of the channels they
studied was not known. Possibly, those L-type channels
differ structurally from CaV1.2a, CaV1.2c, and CaV1.3 and
are consequently modulated by different mechanisms. An-
other possibility is that muscarinic receptors activate differ-
ent signaling pathways in NIH 3T3 and HEK293 cells.
Slow muscarinic inhibition of CaV1.2c was not enhanced
by lowering the concentration of EGTA in the pipette so-
lution (Fig. 2 a). This result indicates that slow inhibition
does not involve Ca2 release from intracellular stores, in
agreement with a previous demonstration that intracellular
Ca2 transients are not required for slow muscarinic inhi-
bition of endogenous M-type K channels in SCG neurons
(Cruzblanca et al., 1998). It is noteworthy, however, that
CCh elicited an additional fast and transient component of
inhibition in recordings made with low EGTA (Fig. 2 a).
Thus, under physiological conditions Gq/11-coupled re-
ceptors may trigger fast and transient Ca2-dependent in-
hibition of L-type channels in addition to triggering slow
and sustained Ca2-independent inhibition.
Our results also indicate that slow muscarinic inhibition
does not require Ca2 influx through L-type channels (Fig.
2 b). This finding agrees with Mathie et al. (1992), who used
cell-attached recordings to study slow muscarinic inhibition
FIGURE 6 Cardiac CaV1.2a and neuronal/neuroendocrine CaV1.3 chan-
nels also undergo slow muscarinic inhibition. (a) Time-plot of slow mus-
carinic inhibition in a cell coexpressing M1 receptors, cardiac CaV1.2a,
skeletal muscle 2a, and cardiac 2a channel subunits. C 
 58 pF; RS 

1.1 M; VE 
 1.2 mV. (b) Time-plot of slow muscarinic inhibition in a
cell coexpressing M1 receptors and neuronal CaV1.3, 2b, and 3 chan-
nel subunits. C 
 16 pF; RS 
 2.9 M; VE 
 9.2 mV.
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of endogenous L-type channels in rat SCG neurons. In their
experiments, the bath was nominally Ca2-free and the
pipette contained 110 mM Ba2 as the sole divalent cation.
Under those conditions, Ca2 influx through membrane
channels should be minimal. Although Ca2-dependent in-
activation is a prominent feature of L-type Ca2 channels
(cf. Adams and Tanabe, 1997), this phenomenon requires
significant Ca2 influx or Ca2 release from internal
sources. Since blocking Ca2 release or influx (Fig. 2) did
not prevent slow muscarinic inhibition, we conclude that
Ca2-dependent inactivation does not contribute to slow
muscarinic inhibition of L-type channels.
Recent studies demonstrate that RGS proteins can influ-
ence G protein-dependent modulation of neuronal N-type,
P/Q-type, and R-type Ca2 channels (Jeong and Ikeda,
1998; Diverse´-Pierluissi et al., 1999; Melliti et al., 1999,
2000, 2001; Kammermeier et al., 2000; Mark et al., 2000).
In the present work, RGS2 and RGS3T blocked slow mus-
carinic inhibition of neuronal L-type Ca2 channels (Fig. 3,
d–f). These findings raise the possibility that by antagoniz-
ing the slow muscarinic pathway, certain RGS proteins may
influence cellular events (such as gene transcription; Mur-
phy et al., 1991; Bading et al., 1993) that are triggered by
Ca2 influx through L-type channels.
Slow muscarinic inhibition of CaV1.2c was insensitive to
the phospholipase C inhibitor U-73122 and also to the
broad-spectrum kinase inhibitor staurosporine (Fig. 4).
These results suggest that the slow muscarinic inhibitory
pathway does not use phospholipase C or protein kinases, in
agreement with previous data from rodent SCG neurons
(Bernheim et al., 1991; Cruzblanca et al., 1998) and
HEK293 cells (Shapiro et al., 2000; Melliti et al., 2001).
However, our results with quinacrine, genistein, okadaic
acid, and CAIN provide new information by suggesting that
phospholipase A2, protein tyrosine kinases, and serine/thre-
onine phosphatases are also not involved in the slow mus-
carinic pathway. Finally, our results with AMP-PNP sug-
gest that phosphorylation is not required for slow
muscarinic inhibition.
Sensitivity to BAPTA has been widely cited as a distin-
guishing characteristic of the slow muscarinic pathway
(Beech et al., 1991; Bernheim et al., 1991; Mathie et al.,
1992; Howe and Surmeier, 1995; Stewart et al., 1999), and
it has been frequently assumed that Ca2 chelation under-
lies the effects of BAPTA. In an earlier study, Beech et al.
(1991) reported that 5,5-dinitro-BAPTA reduced slow
muscarinic inhibition of endogenous N-type Ca2 current in
SCG neurons. In the present experiments, we found that
5,5-dinitro-BAPTA completely blocked slow muscarinic
inhibition of CaV1.2c (Fig. 5). It is unlikely that Ca2
chelation is responsible for this effect, because 5,5-dinitro-
BAPTA binds Ca2 with relatively low affinity (Kd 
 7
mM). Based on these and other results (Beech et al., 1991;
Meza et al., 1999), we conclude that some property of
BAPTA other than Ca2 buffering interferes with the slow
inhibitory pathway.
We found that the cardiac CaV1.2a and the neuronal/
neuroendocrine CaV1.3 channels are also robustly inhibited
through M1 receptors (Fig. 6). It seems reasonable to pre-
dict that CaV1.2a and CaV1.3 are inhibited through the same
slow, voltage-independent and Gq/11-mediated pathway
that we characterized in detail for CaV1.2c, although our
present experiments do not establish this point. The appar-
ently similar responses of these three L-type channels to M1
receptors suggests that the molecular determinants of slow
muscarinic inhibition may be conserved within CaV1.2 and
CaV1.3 families. However, at the amino acid level CaV1.2a
is 95% identical to CaV1.2c (Snutch et al., 1991) and
CaV1.3 is 70% identical to CaV1.2c (Hui et al., 1991;
Seino et al., 1992; Williams et al., 1992). Thus, these L-type
channels share large regions of homology, making it diffi-
cult to identify sequences that could potentially be involved
in slow muscarinic inhibition. Further experiments using
channels with different sensitivities to slow muscarinic in-
hibition are needed to reveal the structural basis for this
form of channel modulation. Nonetheless, our results with
CaV1.2a and CaV1.3 suggest that slow muscarinic inhibition
may be a general characteristic of L-type channels, rather
than a unique property of neuronal CaV1.2c channels.
CaV1.2a is essential for excitation-contraction coupling in
cardiac muscle cells (Na¨bauer et al., 1989), and CaV1.3 is
required for normal sinoatrial node pacemaker activity and
for hearing (Platzer et al., 2000). Thus, slow muscarinic
inhibition of different L-type channels may influence Ca2
influx in a wide variety of cell types and may play important
roles in diverse physiological processes.
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